When FT385 was evaluated against other DUBs, it solely inhibited USP6 at 200 nM in the case of cancer cells, indicating great selectivity in inhibiting the cleavage of Ub-Rho110 at 1 nM IC50 [85]. The gene discussed is USP6; the disease is cancer.